vs
Side-by-side financial comparison of Korro Bio, Inc. (KRRO) and Pineapple Financial Inc. (PAPL). Click either name above to swap in a different company.
Korro Bio, Inc. is the larger business by last-quarter revenue ($1.3M vs $707.3K, roughly 1.8× Pineapple Financial Inc.). On growth, Pineapple Financial Inc. posted the faster year-over-year revenue change (-4.8% vs -43.1%). Pineapple Financial Inc. produced more free cash flow last quarter ($-3.3M vs $-79.1M).
Korro Bio, Inc. is a clinical-stage biotechnology company focused on developing innovative RNA editing therapies for rare and severe genetic diseases. It leverages its proprietary oligonucleotide platform to target disease-causing mutations, with core pipelines covering ophthalmology, respiratory and neuromuscular disorder segments, striving to address unmet medical needs for global patients.
KRRO vs PAPL — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.3M | $707.3K |
| Net Profit | — | $-19.5M |
| Gross Margin | — | 48.9% |
| Operating Margin | — | -2518.8% |
| Net Margin | — | -2756.2% |
| Revenue YoY | -43.1% | -4.8% |
| Net Profit YoY | -136.1% | -3174.1% |
| EPS (diluted) | — | $-1.21 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $707.3K | ||
| Q4 25 | $1.3M | $721.7K | ||
| Q3 25 | $1.1M | $730.5K | ||
| Q2 25 | $1.5M | $746.9K | ||
| Q1 25 | $2.5M | $743.3K | ||
| Q4 24 | — | $766.1K | ||
| Q3 24 | $0 | $598.3K | ||
| Q2 24 | $0 | $736.4K |
| Q1 26 | — | $-19.5M | ||
| Q4 25 | — | $-6.4M | ||
| Q3 25 | $-18.1M | $-1.8M | ||
| Q2 25 | $-25.8M | $-557.7K | ||
| Q1 25 | $-23.4M | $-595.4K | ||
| Q4 24 | — | $-656.9K | ||
| Q3 24 | $-21.0M | $-1.7M | ||
| Q2 24 | $-21.8M | $-848.6K |
| Q1 26 | — | 48.9% | ||
| Q4 25 | — | 49.6% | ||
| Q3 25 | — | 27.8% | ||
| Q2 25 | — | 67.6% | ||
| Q1 25 | — | 43.4% | ||
| Q4 24 | — | 45.9% | ||
| Q3 24 | — | 43.2% | ||
| Q2 24 | — | 44.2% |
| Q1 26 | — | -2518.8% | ||
| Q4 25 | — | -909.1% | ||
| Q3 25 | -1764.9% | -131.3% | ||
| Q2 25 | -1863.2% | -93.3% | ||
| Q1 25 | -981.2% | -80.6% | ||
| Q4 24 | — | -90.5% | ||
| Q3 24 | — | -232.8% | ||
| Q2 24 | — | -121.7% |
| Q1 26 | — | -2756.2% | ||
| Q4 25 | — | -891.6% | ||
| Q3 25 | -1657.0% | -250.3% | ||
| Q2 25 | -1765.1% | -74.7% | ||
| Q1 25 | -917.1% | -80.1% | ||
| Q4 24 | — | -85.7% | ||
| Q3 24 | — | -283.9% | ||
| Q2 24 | — | -115.2% |
| Q1 26 | — | $-1.21 | ||
| Q4 25 | — | $-4.79 | ||
| Q3 25 | $-1.92 | $-0.93 | ||
| Q2 25 | $-2.74 | $-0.05 | ||
| Q1 25 | $-2.49 | $-1.73 | ||
| Q4 24 | — | $-2.60 | ||
| Q3 24 | $-2.26 | $-11.10 | ||
| Q2 24 | $-2.43 | $-0.12 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $75.2M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $51.4M | $27.1M |
| Total Assets | $113.5M | $48.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $75.2M | — | ||
| Q3 25 | $92.5M | — | ||
| Q2 25 | $96.4M | — | ||
| Q1 25 | $115.0M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $137.0M | — | ||
| Q2 24 | $157.4M | — |
| Q1 26 | — | $27.1M | ||
| Q4 25 | $51.4M | $-5.5M | ||
| Q3 25 | $99.0M | $906.7K | ||
| Q2 25 | $115.1M | $842.6K | ||
| Q1 25 | $139.0M | $739.7K | ||
| Q4 24 | — | $1.3M | ||
| Q3 24 | $179.6M | $1.3M | ||
| Q2 24 | $198.1M | $2.0M |
| Q1 26 | — | $48.9M | ||
| Q4 25 | $113.5M | $10.6M | ||
| Q3 25 | $161.6M | $5.4M | ||
| Q2 25 | $180.4M | $4.7M | ||
| Q1 25 | $202.2M | $4.0M | ||
| Q4 24 | — | $4.1M | ||
| Q3 24 | $243.5M | $4.1M | ||
| Q2 24 | $249.6M | $4.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-78.6M | $-3.3M |
| Free Cash FlowOCF − Capex | $-79.1M | $-3.3M |
| FCF MarginFCF / Revenue | -6120.7% | -462.7% |
| Capex IntensityCapex / Revenue | 40.1% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-140.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $-3.3M | ||
| Q4 25 | $-78.6M | $-489.7K | ||
| Q3 25 | $-17.2M | $-507.6K | ||
| Q2 25 | $-19.2M | $397.0K | ||
| Q1 25 | $-24.5M | $-172.6K | ||
| Q4 24 | — | $-663.6K | ||
| Q3 24 | $-16.1M | $-264.7K | ||
| Q2 24 | $-14.6M | $123.0K |
| Q1 26 | — | $-3.3M | ||
| Q4 25 | $-79.1M | $-491.7K | ||
| Q3 25 | $-17.4M | — | ||
| Q2 25 | $-19.4M | — | ||
| Q1 25 | $-24.6M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-21.0M | $-264.7K | ||
| Q2 24 | $-20.6M | $122.7K |
| Q1 26 | — | -462.7% | ||
| Q4 25 | -6120.7% | -68.1% | ||
| Q3 25 | -1592.1% | — | ||
| Q2 25 | -1326.6% | — | ||
| Q1 25 | -963.6% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -44.2% | ||
| Q2 24 | — | 16.7% |
| Q1 26 | — | 0.0% | ||
| Q4 25 | 40.1% | 0.3% | ||
| Q3 25 | 16.1% | — | ||
| Q2 25 | 9.6% | — | ||
| Q1 25 | 4.7% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
